¿¬¼ö°­ÁÂ
´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10
±³À°ÀÏÀÚ : 2023-05-10
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º, ±×·£µåº¼·ë(5F)

±³À°ÁÖÁ¦ : IASS 2023 (Çмú´ëȸ)

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ

´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674

À̸ÞÀÏ : IASS2022@humming.co.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 500,000¿ø  

ºñ°í ÇǺΰú Àü¹®ÀÇ : 5¸¸¿ø·¹Áö´øÆ®, ¿¬±¸¿ø : 2¸¸¿øºñȸ¿ø : 50¸¸¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:20~09:40 What¡¯s new in itch mechanism and therapeutic approaches for atopic dermatitis? Jiehyun Jeon(Korea Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:40~10:00 Characteristics for pediatric atopic dermatitis : What¡¯s the different  adult atopic dermatitis? Sang Eun Lee(Yonsei Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:00~10:20 Understanding of skin microbiome in atopic dermatitis for advance atopic dermatitis treatment Jihyun Lee(Catholic Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:20~10:30 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:30~11:10 Introduction of the concept of minimal disease activity Mark Kirchhof(Ottawa Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:10~11:20 Q&A ( )

ÈÞ½Ä 05¿ù 10ÀÏ 11:20~11:35 Coffee Break ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:35~12:15 Can treatment impact the natural course of atopic dermatitis and comorbidity? Eric simpson(Oregon Health and Science Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:15~12:25 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:25~12:45 Prominent role of type 2 inflammation in skin diseases: beyond atopic dermatitis (Jiyoung Ahn)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:45~12:55 Q&A ( )

½Ä»ç 05¿ù 10ÀÏ 12:55~13:20 Lunch ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 13:20~14:00 Current learning on the applications of atopic dermatitis therapy in real-world practice Stephan Weidinger(Christian-Albrechts Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:00~14:10 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:10~14:50 How does baricitinib real-world evidence compare to randomized controlled trials? Andreas Wollenberg(Ludwig-Maximilian Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:50~15:00 Q&A ( )

ÈÞ½Ä 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:00~15:15 Coffee Break ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:15~15:55 Long-term perspectives in atopic dermatitis Chih-Ho Hong(British Columbia Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:55~16:05 Q&A ( )

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:05~16:25 Treat-to-target in atopic dermatitis : an important strategy for successful treatment Chan Ho Na(Chosun Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:25~16:45 Optimal use of JAK inhibitors for atopic dermatitis based on real-world experiences Min Kyung Shin(Kyung Hee Univ.)

±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:45~17:05 Update on the treatment of pediatric atopic dermatitis Jung-Im Na(Seoul National Univ.)

Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 17:05~17:15 Q&A ( )

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,334 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17

±³À°ÀÏÀÚ : 2024-04-17 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : °­ÈÆ ¿¬¶ôó

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,177 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,281 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ : 2024-04-28

±³À°ÀÏÀÚ : 2024-04-28 ±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦9ȸ ºñ¸¸Àü¹®°¡ ±âÃÊ°úÁ¤ ÁÖÃÖ±â°ü : ´ëÇѺñ¸¸ÇÐȸ ´ã´çÀÚ : ÃÖÀ±Áö ¿¬¶ôó : 02-6941-087

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,146 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä) : 2024-02-25

±³À°ÀÏÀÚ : 2024-02-25 ±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø º»°ü ÁöÇÏ 1Ãþ ±èÁ¾±â Ȧ ±³À°ÁÖÁ¦ : ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä)ÁÖÃÖ±â°ü : ¼­

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,419 , ´ñ±Û¼ö : 0